Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Hepatology|December 16, 2003
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cellsElena Zamara, Erica Novo, Fabio Marra, et al.
Hepatology International|July 24, 2015
Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluationSilvia Gaia, Antonella Olivero, Antonina Smedile, et al.
Oxidative Medicine and Cellular Longevity|August 25, 2020
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox CascadesClaudia Penna, Manuela Aragno, Alessia Sofia Cento, et al.
The British Journal of Nutrition|November 26, 2011
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled studyConcetta Finocchiaro, Olivia Segre, Maurizio Fadda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2026
Pharmacological inhibition of CDK9 counteracts neuroinflammatory impairments in sepsis-associated encephalopathyEnrica Marzani, Gustavo Ferreira Alves, Alon Zemer, et al.
The Journal of Nutritional Biochemistry|March 15, 2018
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo studyRaffaella Mastrocola, Ilario Ferrocino, Erica Liberto, et al.
Nutrients|August 23, 2020
Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic InflammationRaffaella Mastrocola, Debora Collotta, Giulia Gaudioso, et al.
Frontiers in Immunology|September 19, 2022
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsisGustavo Ferreira Alves, Ian Stoppa, Eleonora Aimaretti, et al.
Frontiers in Immunology|April 12, 2019
Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 DiabetesGareth S D Purvis, Massimo Collino, Rodrigo A Loiola, et al.
Circulation Research|November 22, 2017
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells From Type2 Diabetes Patients: Rescue by α-Ketoglutarate and TET-TDG Functional ReactivationFrancesco Spallotta, Chiara Cencioni, Sandra Atlante, et al.
Pageof 8